Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global proton therapy systems market 360° synopsis, 2018 – 2032
2.2 Regional trends (Revenue & Volume)
2.3 Set-up type trends
2.4 Indication trends
2.5 End-use trends
Chapter 3 Proton Therapy Systems Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Increasing prevalence of cancer
3.5.1.2 Growing awareness and diagnosis rates
3.5.1.3 Increasing number of proton therapy offered by many medical establishments
3.5.1.4 Technological advancements
3.5.2 Industry pitfalls & challenges
3.5.2.1 High cost of the device and procedure
3.5.2.2 Availability of alternative treatment approaches
3.6 Growth potential analysis
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 IBA worldwide
4.1.2 Hitachi
4.1.3 Mevion Medical Systems
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Proton Therapy Systems Market Estimates and Forecast, By Set-up Type (Revenue)
5.1 Key trends, by set-up type
5.2 Single room
5.3 Multiple room
Chapter 6 Proton Therapy Systems Market Estimates and Forecast, By Indication (Revenue)
6.1 Key trends, by indication
6.2 Breast cancer
6.3 Lung cancer
6.4 Prostate cancer
6.5 Gastro-intestinal cancer
6.6 Brain cancer
6.7 Others
Chapter 7 Proton Therapy Systems Market Estimates and Forecast, By End-use (Revenue)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Proton therapy centers
7.4 Others
Chapter 8 Proton Therapy Systems Market Estimates and Forecast, By Region (Revenue)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Switzerland
8.3.7 The Netherlands
8.3.8 Denmark
8.3.9 Poland
8.3.10 Sweden
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 New Zealand
8.4.7 Thailand
8.4.8 Vietnam
8.4.9 Indonesia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Turkey
Chapter 9 Company Profiles
9.1 IBA worldwide
9.2 Hitachi
9.3 Mevion Medical Systems
9.4 Optivus Proton Therapy
9.5 Advanced Oncotherapy plc
9.6 Mitsubishi Electric Corporation
9.7 Varian
9.8 Ion Beam Applications SA
9.9 ProTom International
9.10 Provision Healthcare
